Quantity size:
0.2ml
Concentration:
1mg/ml 纤溶酶原激活物抑制因子2/血浆酶原激活酶抑制因子-2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SerpinB2 is a serine proteinase inhibitor of the ovalbumin like B clade of serpins. It was first discovered in the placenta, and given the name PAI-2 because of the ability to inhibit urokinase plasminogen activator (u-PA) at low micromolar efficiency. SerpinB2 also inhibits tissue plasminogen activator (t-PA), but with micromolar efficiency, and PAI-1纤溶酶原激活物抑制因子2/血浆酶原激活酶抑制因子-2抗体 is much more efficient that SerpinB2 on both forms of plasminogen activator. The structure of PAI-2 is not terribly similar to PAI-1, however, which is an E clade serpin.
SerpinB2 is made by many cell types, and is found intracellularly as an unglycosylated kDa protein, and secreted as a 60 kDa protein. SerpinB2 is found in saliva, secreted by gingival fibroblasts, and in the skin. SerpinB2 levels are elevated in serum during pregnancy, and in leukemia, breast cancer and ovarian cancer, although it纤溶酶原激活物抑制因子2/血浆酶原激活酶抑制因子-2抗体 was lowered in some cancers.A shorter SerpinB2 isoform of 382 amino acids, has been reported, with a predicted mass of 43.1 kDa and a pI of 5.69. The shorter form has a deletion just after the start of the mature protein, but it is unclear what the relative production and distribution is for the shorter sequence.
Also known as:
Serpin B2; Serpinb2; SerpinB2; plasminogen activator inhibitor 2; HsT1201; Monocyte Arg serpin; Monocyte Arg-serpin; PAI2A; PAI; PAI-2; PAI 2; PAI2; Placental plasminogen activator 纤溶酶原激活物抑制因子2/血浆酶原激活酶抑制因子-2抗体inhibitor; PAI2_RAT; PLANH2; Plasminogen activator inhibitor 2; Plasminogen activator inhibitor 2 type A; Serpin peptidase inhibitor clade B (ovalbumin) member 2; Urokinase inhibitor.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human PAI-2.
●
纤溶酶原激活物抑制因子2/血浆酶原激活酶抑制因子-2抗体Predicted Molecular Weight: 47kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl079Bo01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Ca01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Cp01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Ga01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Hu01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Mu01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Po01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Ra01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Rb52白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl079Si01白介素6(IL6)多克隆抗体Polyclonal Antibody to Interleukin 6 (IL6)
kl081Ga01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)
kl081Hu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)
kl081Mu01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)
kl081Ra01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)
kl081Si01白介素9(IL9)多克隆抗体Polyclonal Antibody to Interleukin 9 (IL9)
kl083Hu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Mu01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Po01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)
kl083Ra01瘦素受体(LEPR)多克隆抗体Polyclonal Antibody to Leptin Receptor (LEPR)
kl085Bo01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Ca01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Cp01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Hu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Mu01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)
kl085Po01白血病抑制因子(LIF)多克隆抗体Polyclonal Antibody to Leukemia Inhibitory Factor (LIF)